Chen, Allen C.

Brigham and Women's Hospital · Roswell Park Comprehensive Cancer Center · Beth Israel Deaconess Medical Center · Memorial Sloan Kettering Cancer Center · The University of Texas MD Anderson Cancer Center · Bristol-Myers Squibb (United States) · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center

2 papers on CoChat

Most cited papers

Verified
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine
Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers
Cited by 4,656
Verified
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Carbone, D. P., Reck, M., Paz-Ares, L., Creelan, B., Horn, L., Steins, M., Felip, E., van den Heuvel, M. M., Ciuleanu, T.-E., Badin, F., et al. (2017) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 2,503

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free